Ra Capital Management, L.P. Longboard Pharmaceuticals, Inc. Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
A detailed history of Ra Capital Management, L.P. transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 3,289,119 shares of LBPH stock, worth $95 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
3,289,119Holding current value
$95 Million% of portfolio
1.34%Shares
2 transactions
Others Institutions Holding LBPH
# of Institutions
101Shares Held
34.1MCall Options Held
8.5KPut Options Held
31.1K-
Farallon Capital Management LLC San Francisco, CA2.94MShares$84.9 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$80.6 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$72.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$68.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$55.6 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $392M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...